Immunolabeling also demonstrated the co‐localization of oligomeric tau, p62, and ubiquitin in the hippocampus of AD, striatum of PSP, frontal cortex of CBD, and frontal cortex of PiD patients (Figure S11). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.